FDA approves first pre-surgical breast cancer drug

Boston Globe: WASHINGTON — The Food and Drug Administration on Monday approved a biotech drug to become the first medicine to treat breast cancer before surgery.

Perjeta, made by Roche’s Genentech unit, would be an option for women with a form of early-stage breast cancer who face a high risk of having their cancer spread. Surgery to remove tumors is usually the first step in treating most forms of cancer.

Read article